Publications - Life Sciences and Healthcare
China Legal Newsletter - October 2024
This newsletter highlights key recent developments in China’s laws and regulations. Specifically, it focuses on the laws and regulations related to foreign investment, market access, foreign debt administration, data economy, privacy and…
European Parliament gives support to pharmaceutical strategy for Europe
The European Parliament gave its support to the pharmaceutical strategy for Europe, by resolution on November 24, 2021. Two main driving forces behind this strategy, adopted by the European Commission on November 25, 2020, are to support industry in…
The new regulations on observational studies of medicinal products for human use reduce procedures and introduce significant new legislation
Royal Decree 957/2020 simplifies the process for conducting observational studies through a common single evaluation procedure for all studies of this type and by reducing the prior requirements. It also introduces changes in relation to the…
COVID-19: News in the medical devices industry in Europe and in Spain
Below we summarize some of the specific measures adopted in relation to medical devices by the main European and Spanish authorities. These measures are part of the set of new pieces of legislation affecting the pharmaceutical and healthcare…
Pharmaceutical and healthcare industry: the impact of the COVID-19 measures
Some of the measures adopted in recent weeks to tackle the economic and social impact of COVID-19 have special implications for the healthcare and pharmaceutical industry. In this article we analyze the key information that companies in this field…
Pharma Updates 2-2013
Updates Pharma 1-2013
REGULATION 1257/2012 IMPLEMENTING ENHANCED COOPERATION IN THE AREA OF THE CREATION OF UNITARY PATENT PROTECTION
Updates Farma June 2012
The European Patent. Scope and effects of the revised translation. Decision of Barcelona Commercial Court no. 4 of May 7, 2012
Updates Farma May 2012